![effects of glp-1 receptor agonists on neurological complications of diabetes Frontiers glp-1_analogs [TUSOM | Pharmwiki]](https://www.frontiersin.org/files/Articles/1590530/xml-images/fcdhc-06-1590530-g003.webp)
effects of glp-1 receptor agonists on neurological complications of diabetes Frontiers glp-1_analogs [TUSOM | Pharmwiki]
Description
Explore whether the wide health benefits of GLP1 drugssuch as blood sugar control, weight loss, heart and brain protection.
![effects of glp-1 receptor agonists on neurological complications of diabetes Frontiers glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
World Health Organization
![effects of glp-1 receptor agonists on neurological complications of diabetes Frontiers glp-1_analogs [TUSOM | Pharmwiki]](https://medrac.web.unc.edu/wp-content/uploads/sites/22579/2025/03/AD_4nXecYXk7BfwC6adHH808V596nosg2pYs4yDUs6TBM_JMmx7_pGkjqpOwyHWy2Rj2TdJt-SPUxEipYqiO5CftWX-CaAm_fXRTU6dpEuJkuUscaLenZ1xGLWDdf_XVsOIjaZt08BpA4A.png)
CBS News medical correspondent Dr
![effects of glp-1 receptor agonists on neurological complications of diabetes Frontiers glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-024-03412-w/MediaObjects/41591_2024_3412_Fig1_HTML.png)
Medically supervised weight loss injections in Fort Worth
![effects of glp-1 receptor agonists on neurological complications of diabetes Frontiers glp-1_analogs [TUSOM | Pharmwiki]](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-024-01931-z/MediaObjects/41392_2024_1931_Fig5_HTML.png)
Find the Best Option for Your Weight Management Goals.
![effects of glp-1 receptor agonists on neurological complications of diabetes Frontiers glp-1_analogs [TUSOM | Pharmwiki]](https://www.researchgate.net/publication/301332284/figure/tbl1/AS:669013738786825@1536516713499/Differential-Effects-of-GLP-1-Receptor-Agonists-GLP-1-Receptor-Agonists.png)
With antiamyloid antibodies Leqembi (lecanemab) and Kisunla (donanemab) now FDAapproved for early Alzheimers, attention is turning to combination strategies that address multiple disease pathways
![effects of glp-1 receptor agonists on neurological complications of diabetes Frontiers glp-1_analogs [TUSOM | Pharmwiki]](https://journals.physiology.org/cms/10.1152/jn.00228.2024/asset/images/jn-00228-2024r01.png)
